RxDoctor Payments Data

Carlos Laboy Olivieri, MD

Gastroenterology · Arecibo, PRNPI 1407080856

Payments from drug & device makers

What this record shows

This record is dominated by food and beverage: $3,444 of the $4,023 with a category attached, or 85.6%. 14 manufacturers reported payments, led by AbbVie at 40.1% of the total.

$4,023in general payments, 2019–2025

Across 99 payments — averaging $40.63 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AbbVie$2K
  • Johnson & Johnson$655
  • Medtronic$559
  • E.r. Squibb & Sons, L.L.C.$437
  • Gilead$170
  • Madrigal Pharmaceuticals$132
  • plus $458 from 8 others

What the payments were for

  • Travel & lodging$55914%
  • Food & beverage$3,44486%
  • Education$190%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
AbbVie55$1,612
Johnson & Johnson19$655
Medtronic5$559
E.r. Squibb & Sons, L.L.C.4$437
Gilead4$170
Madrigal Pharmaceuticals1$132
Janssen Scientific Affairs, LLC1$123
Olympus Latin America, Inc.1$102
Merck3$63
KCI USA, Inc.1$49
Eli Lilly Export S.A. Puerto Rico Branch1$49
PBG Puerto Rico LLC2$34
Smith+Nephew1$21
Amgen1$17

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$4,023 in reported general payments places this provider in the 70th percentile of 198 gastroenterology providers in Puerto Rico.

See all gastroenterology providers in Puerto Rico

Medicare billing

Part B allowed, 2024
$2,697
Medicare patients
17
Services billed
30

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
SuprepSodium, Potassium,mag Sulfates151$17,851
SutabSod Sulf/Pot Chloride/Mag Sulf69$11,539
Sucralfate107$9,446
Pantoprazole Sodium248$2,149
Famotidine307$2,070
Sod Sulf-Potass Sulf-Mag SulfSodium, Potassium,mag Sulfates16$1,326
Esomeprazole Magnesium25$825
Entecavir13$474
Clarithromycin13$309
Dicyclomine Hcl23$263
Omeprazole43$207
Propranolol Hcl12$168
Amoxicillin14$146

Paid to pharmacies, not to this prescriber.

Other gastroenterology in Arecibo

See the full list for Puerto Rico

Where these figures come from

Is this you, or does something look wrong? →